Board of Directors
The DZHK is headed by a three-member Board of Directors. The Chairman of the Board is Prof. Dr. Thomas Eschenhagen (University Hospital Hamburg-Eppendorf). The other Board members are Prof. Dr. Gerd Hasenfuß (University Medical Center Göttingen) and Prof. Dr. Thomas Sommer (Max Delbrück Center for Molecular Medicine in the Helmholtz Association).
The DZHK is an association whose statutes grant the partner sites a high level of autonomy and participation in the General Assembly (one vote per partner site). The General Assembly comprises representatives of the DZHK-member institutions.
The Genreal Assembly meets twice a year in Berlin. It is the highest organ of the association and decides upon all strategic matters. In return, all DZHK-member institutions are committed to actively participate in the committees, to comply with basic rules of their partner site and to implement the overall strategy.
The Research Coordinating Committee (RCC)
The Research Coordinating Committee (RCC) is responsible for the scientific strategy of the DZHK. It develops ideas, addresses strategy-relevant issues and prepares all matters for the General Assembly. The RCC meets monthly and comprises the Board of Directors, the partner site speakers, representatives from each partner institution and a representative of the Young-DZHK. Several permanent guests represent important DZHK-activities such as the Central Data Management.
Scientific Advisory Board
|Thomas Voit (chairperson)||Biomedical Research Centre, UCL Institute of Child Health, Great Ormond Street Hospital||London, UK|
|Elizabeth McNally (vice-chairperson)||Northwestern University||Chicago, USA|
|John Cleland||Imperial College London||London, UK|
|Alan Daugherty||University of Kentucky||Lexington, USA|
|Garret A. FitzGerald||Institute for Translational Medicine and Therapeutics||Philadelphia, USA|
|Alexandra J. Lansky||Yale School of Medicine||New Haven, USA|
|Timothy A. McKinsey||University of Colorado Denver||Aurora, USA|
|Frank Misselwitz||Bayer HealthCare Pharmaceuticals||Wuppertal, Germany|
|Vasan Ramachandran||Boston University School of Medicine||Boston, USA|
|Frans Van de Werf||Katholieke Universität Leuven||Leuven, Belgien|
|Wiek van Gilst||University Medical Center Groningen||Groningen, Netherlands|
|Bianca Wittig||AbbVie Deutschland GmbH||Wiesbaden, Germany|
Commission of Donors (KdZG)
BMBF and the ten German states where partner site headquarters are located.
- Mecklenburg-Hither Pomerania
- Lower Saxony
In strategic as well as essential financial, organisational and personnel questions, the Board of Directors and the General Assembly of Members are required to obtain the approval of the Commission of Donors.